EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

An Experimental Study to Optimize Neuromuscular Blockade Protocols in Cynomolgus Macaques: Monitoring, Doses, and Antagonism

Hélène Letscher iD, Julien Lemaitre iD, Emma Burban iD, Roger Le Grand iD, Pierre Bruhns iD, Francis Relouzat iD, Aurélie Gouel-Chéron iD

Journal of Medical Primatology · 2024

DOI: 10.1111/jmp.12736 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Primatology, 2024. Verfasst von Hélène Letscher und 6 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Autoimmune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-…. Hauptthemen laut MEDLINE: Macaca fascicularis, Neuromuscular Blockade, Rocuronium. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Labex Immuno-Oncology, the Agence Nationale de la Recherche (ANR), the Institut National de la Santé et de la Recherche Médicale (INSERM).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neuromuscular blocking agents (NMBAs) are a crucial component of anesthesia and intensive care through the relaxation of skeletal muscles. They can lead to adverse reactions such as postoperative residual neuromuscular block. Only one agent is capable of an instant block reversal in deep block situations, but is restricted to aminosteroid agents. Among animal models, non‐human primates are an essential model for a great diversity of human disease models. The main objective of this study was to establish a model for NMBA monitoring with current available drugs before testing new reversal agents.

Methods

Seven healthy male cynomolgus macaques were randomly assigned to this study. Experiments using macaques were approved by the local ethical committee (CEtEA #44). All animals were anesthetized according to institutional guidelines, with ketamine and medetomidine, allowing IV line placement and tracheal intubation. Anesthesia was maintained with isoflurane. Either rocuronium bromine (with or without sugammadex reversal) or atracurium besylate was evaluated. Monitoring was performed with two devices, TOF‐Watch and ToFscan, measuring the T4/T1 and the T4/Tref ratios, respectively. Nonparametric Mann–Whitney statistical analyses were done when indicated.

Results

NMBA monitoring required adaptation compared to humans, such as stimulus intensity and electrode placement, to be efficient and valid in cynomolgus macaques. When administered, both NMBAs induced deep and persistent neuro‐muscular block at equivalent doses to clinical doses in humans. The rocuronium‐induced profound neuromuscular block could be reversed using the cyclodextrin sugammadex as a reversal agent. We report no adverse effects in these models by clinical observation, blood chemistry, or complete blood count.

Conclusion

These results support the use of non‐human primate models for neuromuscular block monitoring. This represented the first step before the forthcoming testing of new NMBA‐reversal agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Macaca fascicularisNeuromuscular BlockadeRocuroniumAnimalsMaleNeuromuscular Nondepolarizing AgentsAtracuriumAndrostanolsDose-Response Relationship, DrugSugammadexNeuromuscular Blocking Agents

Stichwörter der Autor:innen

anesthesiaanimal modelantagonismmonitoringneuromuscular blocking agent

Substanzen

RocuroniumNeuromuscular Nondepolarizing AgentsAtracuriumAndrostanolsSugammadexNeuromuscular Blocking Agents

Autor:innen und Institutionen

  • Université Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Autoimmune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses and Le Kremlin-Bicêtre, France.
  • Institut Pasteur, Université Paris-Cité, INSERM UMR1222, Antibodies in Therapy and Pathology, Paris, France.
  • Paris City University, Paris, France.
  • Anaesthesiology and Critical Care Medicine Department, DMU PARABOL, Bichat Hospital, AP-HP, Paris, France.

ORCID-Profile: Hélène Letscher, Julien Lemaitre, Emma Burban, Roger Le Grand, Pierre Bruhns, Francis Relouzat, Aurélie Gouel-Chéron

Förderung

  • Labex Immuno-Oncology
  • the Agence Nationale de la Recherche (ANR)
  • the Institut National de la Santé et de la Recherche Médicale (INSERM)
  • the Institut Pasteur
  • Institut National de la Santé et de la Recherche Médicale

Zitieren

APA

Letscher, H., Lemaitre, J., Burban, E., Le Grand, R., Bruhns, P., Relouzat, F., & Gouel-Chéron, A. (2024). An Experimental Study to Optimize Neuromuscular Blockade Protocols in Cynomolgus Macaques: Monitoring, Doses, and Antagonism. Journal of Medical Primatology. https://doi.org/10.1111/jmp.12736

Vancouver

Letscher H, Lemaitre J, Burban E, Le Grand R, Bruhns P, Relouzat F, et al. An Experimental Study to Optimize Neuromuscular Blockade Protocols in Cynomolgus Macaques: Monitoring, Doses, and Antagonism. Journal of Medical Primatology. 2024. doi:10.1111/jmp.12736

BibTeX
@article{Letscher2024,
  author = {Letscher, Hélène and Lemaitre, Julien and Burban, Emma and Le Grand, Roger and Bruhns, Pierre and Relouzat, Francis and Gouel-Chéron, Aurélie},
  title = {An Experimental Study to Optimize Neuromuscular Blockade Protocols in Cynomolgus Macaques: Monitoring, Doses, and Antagonism},
  journal = {Journal of Medical Primatology},
  year = {2024},
  doi = {10.1111/jmp.12736}
}
Kostenlos starten →